ProMIS Neurosciences seperates from COO Malenfant, terminates COO position

On February 14 ProMIS Neurosciences (PMN) separated with Gavin T. Malenfant as Chief Operating Officer of the Company, effective as of February 14… In connection with the Separation, Malenfant and the company intend to enter into a Separation Agreement pursuant to which Malenfant will receive severance benefits in exchange for a release pursuant to the terms of his employment agreement with the company… The company also terminated the Chief Operating Officer position, and does not intend to replace Mr. Malenfant. This information is contained in a company 8k filing…